Medical Lead - DACH Region

Lieu: Germany - Munich

Fonction: Medical Affairs

Niveau de Séniorité: Senior Manager

Medha Khanna

Senior Talent Acquisition Manager

Conditions pour les agences de placement

Votre profil

At Vifor Pharma, we have an opportunity for an experienced medical affairs professional to join our global medical affairs team for our rare diseases business unit in Germany covering the DACH region. 

As a Medical Lead for disease, the incumbent would lead a team of MSLs. In addition, you will  ensure the development of the medical affairs strategy of the rare disease drugs portfolio and operationalization of this strategy in region DACH

This position reports to our Global Medical Affairs function based in Switzerland but you will ensure close collaboration with our German affiliate. 

Your responsibilities will include:

  • Provide medical affairs leadership for the rare disease drug therapeutic area in DACH
  • Ensure the development and execution of the DACH medical plan in support of best clinical practices and overall objectives aligned with Global
  • Medical Affairs plans and brand strategic plan (developed jointly with Medical, Marketing and Market Access)
  • Provide medical leadership, insight and strategy to all medical activities, collaborating across functions
  • Lead the implementation of medical affairs practices to assess new indications, the treating community, patient pathways, identifying patients for clinical research and to develop a thorough understanding of the disease area
  • Support and advise cross-functional teams to ensure patient-focused activities at all times
  • Initiate and support medical affairs activities, such as KOL engagement (advisory boards, professional organizations), medical education, medical publications and new data generation including investigator initiated research
  • Support reimbursement applications in UK through development of appropriate medical documents and provision of medical expertise with internal and external partners for HTA process.
  • Medical leadership of early access programs in DACH region including liaison with KOL experts and program design, implementation and analysis

We would like to welcome the following experience and skills for the role:

  • Medical (M.D.) or Scientific education (Ph.D., Pharm. D.)
  • Minimum 5 years of experience in the pharmaceutical industry (Medical Affairs or Clinical Development)
  • Medical experience with Orphan Drugs/specialized technologies
  • Previous direct experience with HTA applications and management of early access programs in DACH
  • Demonstrated availability to accurately and effectively evaluate medical scientific literature. Knowledge of study design and conduct
  • Proven relationship building skills with key opinion leaders
  • Understanding of medical aspects of therapeutic area along with willingness to develop in-depth expertise
  • Experience of working with commercial and market access teams as well a strong focus on patient centricity and safety
  • Professional level in German and English, both in oral and in written communications
  • Excellent user of Office Programs (Word, Excel, PowerPoint)

A propos de nous

Le groupe Vifor Pharma est une entreprise pharmaceutique internationale spécialisée. Son ambition est de devenir le leader mondial dans les domaines de la carence en fer, de la néphrologie et des traitements cardio-rénaux. L’entreprise est le partenaire de choix pour les médicaments et les solutions innovantes axées sur le patient. Le groupe Vifor Pharma aspire à aider les patients du monde entier atteints de maladies graves et chroniques à mener une vie meilleure et plus saine. La société développe, fabrique et commercialise des produits pharmaceutiques offrant des soins de précision aux patients. Le groupe Vifor Pharma occupe une position de premier plan dans toutes ses activités clés. Il se compose des entreprises suivantes: Vifor Pharma; Vifor Fresenius Medical Care Renal Pharma (sa société commune avec Fresenius Medical Care); et OM Pharma.

Le groupe Vifor Pharma a son siège en Suisse et est coté à la Bourse suisse (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).

Pour de plus amples informations, veuillez consulter

Afficher/masquer le contenu


Conditions pour les agences de placement